Quantitative analysis of p185(HER-2/neu) protein in breast cancer and its association with other prognostic factors

International Journal of Cancer

Volumn 74, Issue 2, 1997, Pages 175-179

  Valerón, Pilar F ^a   Chirino, Ricardo ^a   Vega, Victor ^b   Falcón, Orlando ^c   Rivero, Juan F ^a   Torres, Santiago ^a   León, Laureano ^c   Fernández, Leandro ^a   Pestano, José ^a   Díaz Chico, Bonifacio ^a   D́az Chico, Juan C ^a  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^c HOSPITAL UNIVERSITARIO MATERNO INFANTIL DE CANARIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; HORMONE RECEPTOR; ONCOPROTEIN; PROTEIN S II; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CATHEPSIN D; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEINS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR SUPPRESSOR PROTEINS;

EID: 0030945762     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970422)74:2<175::AID-IJC6>3.0.CO;2-W     Document Type: Article

References (21)

1. AN, H.X., NIEDERACHER, D., BECKMANN, M.W., GOHRING, U.J., SCHARL, A., PICARD, F., VAN ROEYEN, C., SCHNURCH, H.G. and BENDER, H.G., ErbB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast-carcinoma tissues. Int. J. Cancer, 64, 291-297 (1995).
2. BERNS, E.M.J.J., KLIJN, J.G.M., VAN PUTTEN, W.L.J., VAN STAVEREN, I.L., PORTENGEN, H. and FOEKENS, J.A., c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res., 52, 1107-1113 (1992).
3. CARNEY, W.P., HARMER, P.J., PETIT, D., RETOS, C., GREENE, R., ZABRECKY, J.R., MCKENZIE, S., HAYES, D., KUFE, D., DELELLIS, R., NABER, S. and WOLFE, H., Detection and quantitation of the human neu oncoprotein. J. Tumor Marker Oncol., 6, 53-72 (1991).
4. CIOCCA, D.R., FUJIMURA, F.K. and TANDON, A.K., Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers. J. nat. Cancer Inst., 84, 1279-1282 (1992).
5. CLARK, G.M. and MCGUIRE, W.L., Follow-up study of HER-2/neu amplification in primary breast cancer. Cancer Res., 51, 944-948 (1991).
6. DATI, C., ANTONIOTTI, S., TAVERNA, D., PERROTEAU, I. and DE BORTOLI, M., Inhibition of c-erbB-2 oncogene expression by estrogens in human breast-cancer cells. Oncogene, 5, 1001-1006 (1990).
7. DITTADI, R., DONISI, P.M., BRAZZALE, A., MARCONATO, R., SPINA, M. and GION, M., Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parameters. Anticancer Res., 12, 2005-2010 (1992).
8. ENG, TAN, P., BENZ, C.C., DOLLBAUM, C., MOORE, D.H., EDGERTON, S.M., ZAVA, D.T. and THOR, A.D., Prognostic value of cathepsin-D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assay. Ann. Oncol. 5, 329-336 (1994).
9. FOEKENS, J.A., VAN PUTTEN, W.L., PORTENGEN, H., DE KONING, H.Y., THIRION, B., ALEXIEVA-FIGUSH, J. and KLIJN, J.G., Prognostic value of pS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis. J. clin. Oncol. 11, 899-908 (1993).
10. HORWITZ, K.B. and MCGUIRE, W.L., Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J. biol. Chem., 253, 2223-2228 (1978).
11. ISOLA, J., WEITZ, S., VISAKORPI, T., HOLLI, K., SHEA, R., KHABBAZ, N. and KALLIONEMI, O.P., Cathepsin-D expression detected by immunohistochemistry has independent prognostic value in axillary-node-negative breast cancer. J. clin. Oncol. 11, 36-43 (1993).
12. KALLIONIEMI, O.P., HOLLI, K., VISAKORPI, T., KOIVULA, T., HELIN, H.H. and ISOLA, J.J., Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int. J. Cancer. 49, 650-655 (1991).
13. MARSIGLIANTE, S., MUSCELLA, A., CIERDO, V., BARKER, S., LEO, G., BAKER, V., MOTTAGH, A., VINSON, G.P. and STORELLI, C., Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer: its correlation with sex steroid receptors, cathepsin D and histologic grades. Cancer Lett., 75, 195-206 (1993).
14. MASIAKOWSKI, P., BREATHNACH, R., BLOCH, J., GANNON, F., KRUST, A. and CHAMBON, P., Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast-cancer cell line. Nucleic Acids Res., 10, 7895-7903 (1982).
15. PIETRAS, R.J., ARBOLEDA, J., REESE, D.M., WONGVIPAT, N., PEGRAM, M.D., RAMOS, L., GORMAN, C.M., PARKER, M.G., SLIWKOWSKI, M.X. and SLAMON, D.J., HER-2 tyrosine pathway targets estrogen receptor and promotes hormone-independent growth in human breast-cancer cells. Oncogene, 10, 2435-2446 (1995).
16. READ, L.D., KEITH, D., JR., SLAMON, D.J. and KATZENELLENBOGEN, B.S., Hormonal modulation of HER-2/neu proto-oncogene messenger ribonucleic acid and p185 protein expression in human breast-cancer cell lines. Cancer Res., 50, 3947-3951 (1990).
17. SHAHEEN, R.M., MISELJIC, S., WIEHLE, R.D. and WITTLIFF, J.L., Relations between cathepsin-D expression and other prognostic factors in breast carcinomas. Clin. Chem., 41, 1585-1591 (1995).
18. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. and PRESS, M.F., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712 (1989).
19. TANDON, A.K., CLARK, G.M., CHAMNESS, G.C., ULLRICH, A. and MCGUIRE, W.L., HER-2/neu oncogene protein and prognosis in breast cancer. J. clin. Oncol., 7, 1120-1128 (1989).
20. TETU, B. and BRISSON, J., Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy. Cancer, 73, 2359-2365 (1994).
21. VALFRÒN, P.E. CHIRINO, R., FERNANDEZ, L., TORRES, S., NAVARRO, D., AGUIAR, J., CABRERA, J.J., DIAZ-CHICO, B.N. and DIAZ-CHICO, J.C., Validation of a differential PCR and an ELISA procedure in studying HER-2/neu status in breast cancer. Int. J. Cancer. 65, 129-133 (1996).